Trial intelligence / Profile preview

PRP-EpiHeal: Platelet-Rich Plasma for Episiotomy Wound Healing

NCT07669285Not yet recruiting

Sponsor
Saint Andrew Emergency County Hospital Constanta
Start
Jun 2026
Primary completion
Jun 2026
Countries
1
01

Overview

Randomised, open-label trial of autologous platelet-rich plasma in episiotomy (2 arms), sponsored by Saint Andrew Emergency County Hospital Constanta. Primary endpoint: REEDA Score at 6 weeks. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

autologous platelet-rich plasma
03

Conditions

episiotomy

Beyond the preview

Go deeper on NCT07669285.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07669285.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call